Fundraising Fox
Model Medicines
La Jolla, US · Founded 2019 · Delaware corporation · 15 employees on LinkedIn · 5 known investors
Find your way into Model Medicines
2,286 people in our graph can introduce you to the Model Medicines team.
Sign up to see every warm intro you have to Model Medicines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Model Medicines team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Model Medicines is an AI-powered biotechnology company that uses computation to discover and engineer small molecule drugs targeting disease-driving biological mechanisms. The company has programs in infectious disease, oncology, and inflammation, with compounds in development including a broad-spectrum antiviral and a BRD4 inhibitor.
Founders & leadership
Model Medicines was founded in 2019 by Daniel Haders, Daniel Haders II, Ph.D, and Sean Russell.
Investors · 5
How we know: 8VC's portfolio page · a partner's Signal profile · prnewswire.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$26.6M disclosed across 5 rounds · 2020–2025
- $4.1MraisedNov 2021 · 2 sources
8VC, Irving Investors, Nex Cubed, Particle X
Source ↗
▶$3.3MraisedNov 2025 · 10 investors · OtherRule 506(b)
- Daniel HadersExecutive Officer
- Offering amount
- $5M
- Amount sold
- $3.3M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.8MraisedOct 2024 · 43 investors · BiotechnologyRule 506(b)
- Kip QuackenbushExecutive Officer, Director
- Daniel HadersExecutive Officer, Director
- Marlon EvansExecutive Officer, Director
- Amount sold
- $14.8M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$950KraisedFeb 2024 · 10 investors · BiotechnologyRule 506(b)
- Daniel HadersExecutive Officer, Director
- Marlon EvansExecutive Officer, Director
- Kip QuackenbushExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $950K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$3.5MraisedNov 2021 · 5 investors · Other TechnologyRule 506(b)
- Kip QuackenbushExecutive Officer, Director
- Marlon EvansExecutive Officer, Director
- Daniel HadersExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Model Medicines went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Model Medicines.
In the news
Frequently asked questions
- What does Model Medicines do?
- Model Medicines is an AI-powered biotechnology company that uses computation to discover and engineer small molecule drugs targeting disease-driving biological mechanisms. The company has programs in infectious disease, oncology, and inflammation, with compounds in development including a broad-spectrum antiviral and a BRD4 inhibitor.
- Who founded Model Medicines?
- Model Medicines was founded by Daniel Haders, Daniel Haders II, Ph.D, Sean Russell in 2019.
- Who are Model Medicines's investors?
- Model Medicines's investors include 8VC, Particle, Irving Investors, Nex Cubed.
- How much funding has Model Medicines raised?
- Model Medicines has disclosed $26.6M raised across 5 rounds.
- Where is Model Medicines headquartered?
- Model Medicines is headquartered in La Jolla, US.